Results We included 1,647,238 patients who were prescribed a GLP-1 RA between January 2024 and July 2025, with 6,059,445 total GLP-1 RA prescriptions during this period
Semaglutide must not be given to people with a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2) or medullary thyroid carcinoma (MTC)
Zabezhinski (2002) Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats Cancer Letters, Volume 183, Issue 1, 8 September 2002, Pages 1-8
Expert Perspective To put these experiences into context, we asked Alessandro Grenci, Superintendent Pharmacist at Medino , for his view: "Cravings on Wegovy are highly individual
Always consult your healthcare provider before starting any peptide regimen to ensure safety and appropriateness
Follow standard laboratory reconstitution and handling protocols